SRPT compared with ESTC: revenue, margins and what each company keeps, and the suppliers and customers both name

SRPTSarepta Therapeutics, Inc.

Mkt capRevenueRevenue

ESTCElastic N.V.

Mkt capRevenueRevenue

Compare

SRPTSarepta Therapeutics, Inc.

ESTCElastic N.V.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SRPT

0 of 2at or beyond implied

Reportimpliedrealized× implied

Nov 6 '26±6.5%▲+1.42%×0.22

Aug 6 '26±9.2%▲+5.34%×0.58

May 7 '26—▼−9.68%—

Feb 26 '26—▼−8.01%—

ESTC1 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Aug 28 '26±17.1%▲+19.31%×1.13

= impliedSRPT realized, solidESTC realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

SRPTSarepta Therapeutics, Inc.

17.79▲+1.23%· post 17.79

Mkt cap$1.9BRevenue$381MQ3 FY26Revenue$2.2BFY25

ESTCElastic N.V.

86.07▲+2.22%· post 86.07

ClosedNov 6 '26

Mkt cap$9.0BRevenue$478MQ1 FY27Revenue$1.7BFY26

Compare

ClosedNov 6 '26

SRPTSarepta Therapeutics, Inc.

ESTCElastic N.V.

17.79▲+1.23%post 17.79

Price

86.07▲+2.22%post 86.07

$1.9B

Mkt cap

$9.0B

Q3 FY26$381M

Revenue

$478MQ1 FY27

FY25$2.2B

Revenue

$1.7BFY26

SRPT17.79▲+1.23%vsESTC86.07▲+2.22%ClosedNov 6 '26